Ashley Gould

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

October 01, 2012
Ashley Gould, 23andMe’s Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative...
Read More

23andMe at FDA/CDRH Public Meeting on Oversight of Laboratory Developed Tests (LDTs)

July 20, 2010
The FDA/CDRH Public Meeting on Oversight of Laboratory Developed Tests (LDTs) took place yesterday and today (July 19 and 20) in Washington, DC. Webcasts of both days will be available...
Read More